Skip to main content
Ono Pharmaceutical Co., Ltd. (TYO:4528)
Japan flag Japan · Delayed Price · Currency is JPY
1,708.50
-18.00 (-1.04%)
Aug 15, 2025, 3:30 PM JST

Ono Pharmaceutical Revenue

Ono Pharmaceutical had revenue of 127.54B JPY in the quarter ending June 30, 2025, with 8.38% growth. This brings the company's revenue in the last twelve months to 496.73B, down -0.72% year-over-year. In the fiscal year ending March 31, 2025, Ono Pharmaceutical had annual revenue of 486.87B, down -3.14%.

Revenue (ttm)
496.73B
Revenue Growth
-0.72%
P/S Ratio
1.62
Revenue / Employee
115.87M
Employees
4,287
Market Cap
802.61B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025486.87B-15.80B-3.14%
Mar 31, 2024502.67B55.49B12.41%
Mar 31, 2023447.19B85.83B23.75%
Mar 31, 2022361.36B52.08B16.84%
Mar 31, 2021309.28B16.86B5.77%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Chugai Pharmaceutical 1,196.22B
Takeda Pharmaceutical Company 4,480.25B
Daiichi Sankyo Company 1,924.68B
HOYA Corporation 876.09B
Otsuka Holdings 2,401.70B
Terumo 1,037.94B
Astellas Pharma 1,944.99B
Shionogi & 440.50B
Revenue Rankings

Ono Pharmaceutical News

More News